Matrix Laboratories

Pro
Kotak Alts-backed Matrix Pharma buys bulk-drugs maker

Healthcare

09 October, 2025

Kotak Alts-backed Matrix Pharma buys bulk-drugs maker

Bulk-drugs maker Matrix Pharmacorp Pvt Ltd has struck a deal to take control of an Indian company, two years after ......

Premium

General

29 February, 2024

Grapevine: KKR mulls JB Pharma sale; Bharti eyes Del Monte JV exit

Private equity firm KKR & Co. is exploring options for a potential sale of its 53.8% controlling stake in Mumbai-based ......

Premium

Healthcare

03 January, 2024

Kotak's second special situations PE fund bankrolling big-ticket pharma acquisition

Kotak Alternate Asset Managers (previously Kotak Investment Advisors), the alternative investment arm of Kotak Group, ......

Healthcare

03 October, 2023

Matrix Labs founder Nimmagadda Prasad's firm buys Viatris' India API business

Viatris Inc., the result of the merger between Mylan NV and Pfizer Inc.’s Upjohn unit in 2020, has sold two ......

Premium

Healthcare

04 September, 2017

Company watch: Concord Biotech eyes new opportunities after Quadria's backing

Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20 years ago to start his entrepreneurial journey. The Ahmedabad-based biotechnology ......

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News